140 related articles for article (PubMed ID: 3829494)
1. Effect of razoxane on metastases from colorectal cancer.
Hellmann K; Gilbert J; Evans M; Cassell P; Taylor R
Clin Exp Metastasis; 1987; 5(1):3-8. PubMed ID: 3829494
[TBL] [Abstract][Full Text] [Related]
2. Prospective serial liver ultrasound scanning in resectable colorectal cancer treated with adjuvant razoxane.
Taylor RH; Gilbert JM; Evans MG; Lane HG; Cassell PG
Clin Exp Metastasis; 1984; 2(4):321-31. PubMed ID: 6399698
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial of oral adjuvant razoxane (ICRF 159) in resectable colorectal cancer: five-year follow-up.
Gilbert JM; Hellmann K; Evans M; Cassell PG; Taylor RH; Stoodley B; Ellis H; Wastell C
Br J Surg; 1986 Jun; 73(6):446-50. PubMed ID: 3521784
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant oral razoxane (ICRF-159) in resectable colorectal cancer.
Gilbert JM; Hellmann K; Evans M; Cassell PG; Stoodley B; Ellis H; Wastell C
Cancer Chemother Pharmacol; 1982; 8(3):293-9. PubMed ID: 7127660
[TBL] [Abstract][Full Text] [Related]
5. A controlled prospective trial of adjuvant razoxane in resectable colorectal cancer.
Gilbert JM; Cassell PC; Ellis H; Wastell C; Hellmann K; Evans MG; Stoodley BJ
Recent Results Cancer Res; 1981; 79():48-58. PubMed ID: 7029684
[TBL] [Abstract][Full Text] [Related]
6. Razoxane, metastasis and adjuvant chemotherapy.
Hellmann K
Clin Exp Metastasis; 1987; 5(1):1-2. PubMed ID: 3829493
[No Abstract] [Full Text] [Related]
7. Effect of adjuvant chemo- or immunotherapy on the prognosis of colorectal cancer operated for cure.
Wunderlich M; Schiessel R; Rainer H; Rauhs R; Kovats E; Schemper M; Dittrich C; Micksche M; Sedlacek HH
Br J Surg; 1985 Sep; 72 Suppl():S107-10. PubMed ID: 3899250
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy.
Kamoshida S; Matsuoka H; Ishikawa T; Maeda K; Shimomura R; Inada K; Tsutsumi Y
Jpn J Clin Oncol; 2004 Oct; 34(10):594-601. PubMed ID: 15591457
[TBL] [Abstract][Full Text] [Related]
9. [Cooperative study of surgical adjuvant chemotherapy for colorectal cancer. Cooperative Study Group of Surgical Adjuvant Chemotherapy for Colorectal Cancer in Japan].
Kunii Y; Kikuchi K
Gan To Kagaku Ryoho; 1995 Sep; 22(10):1369-75. PubMed ID: 7668872
[TBL] [Abstract][Full Text] [Related]
10. [Studies on the effects of adjuvant chemotherapy on the survival period of patients with colorectal carcinoma].
Jo T
Nihon Geka Gakkai Zasshi; 1985 Jun; 86(6):697-708. PubMed ID: 3929067
[TBL] [Abstract][Full Text] [Related]
11. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of experimental colorectal cancer by razoxane (ICRF-159).
Gilbert JM; Thompson EM; Slavin G; Kark AE
Br J Surg; 1984 Aug; 71(8):600-3. PubMed ID: 6743979
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant therapy for colorectal carcinoma.
Kim R; Yamaguchi Y; Toge T
Anticancer Res; 2002; 22(4):2413-8. PubMed ID: 12174936
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04).
Mamounas E; Wieand S; Wolmark N; Bear HD; Atkins JN; Song K; Jones J; Rockette H
J Clin Oncol; 1999 May; 17(5):1349-55. PubMed ID: 10334518
[TBL] [Abstract][Full Text] [Related]
15. Contributions of pathologic margins and Dukes' stage to local recurrence in colorectal carcinoma.
Devereux DF; Deckers PJ
Am J Surg; 1985 Mar; 149(3):323-6. PubMed ID: 3976986
[TBL] [Abstract][Full Text] [Related]
16. Effect of occult hepatic metastases on survival after curative resection for colorectal carcinoma.
Finlay IG; McArdle CS
Gastroenterology; 1983 Sep; 85(3):596-9. PubMed ID: 6873606
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer.
Taylor I; Machin D; Mullee M; Trotter G; Cooke T; West C
Br J Surg; 1985 May; 72(5):359-63. PubMed ID: 3888335
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of ICRF-159 in patients with metastatic colorectal carcinoma previously exposed to systemic chemotherapy.
Bellet RE; Engstrom PF; Catalano RB; Creech RH; Mastrangelo MJ
Cancer Treat Rep; 1976 Sep; 60(9):1395-7. PubMed ID: 1016973
[No Abstract] [Full Text] [Related]
19. Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04.
Wolmark N; Rockette H; Mamounas E; Jones J; Wieand S; Wickerham DL; Bear HD; Atkins JN; Dimitrov NV; Glass AG; Fisher ER; Fisher B
J Clin Oncol; 1999 Nov; 17(11):3553-9. PubMed ID: 10550154
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality.
Al-Mulla F; Going JJ; Sowden ET; Winter A; Pickford IR; Birnie GD
J Pathol; 1998 Jun; 185(2):130-8. PubMed ID: 9713338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
